3531.6000 -83.00 (-2.30%)
NSE Sep 25, 2025 15:31 PM
Volume: 208.1K
 

3531.60
-2.30%
Sharekhan
Q4FY24 results were good where sales grew by 10% y-o-y (2% below our estimates), EBITDA grew by 21% y-o-y (0.8% above our estimates) and PAT grew by 56% y-o-y (10% above our estimates).
Number of FII/FPI investors increased from 913 to 923 in Jun 2025 qtr.
More from Torrent Pharmaceuticals Ltd.
Recommended